Stay updated on APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial

Sign up to get notified when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding APL-2 for warm Autoimmune Hemolytic Anemia and the update of the revision number from v2.14.4 to v2.15.0.
    Difference
    24%
    Check dated 2025-04-16T11:21:23.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:29:55.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:38:58.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T23:12:20.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T16:39:30.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T11:52:43.000Z thumbnail image

Stay in the know with updates to APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.